(Q33875158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Overexpression of BRCA2 gene in sporadic breast tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Noguès C

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Lidereau R

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

5232-5238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1202903

31 October 2019

exact match

0 references

cites work

Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

BRCA2 germline mutations in male breast cancer cases and breast cancer families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Human beta-actin retropseudogenes interfere with RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Quantitation of RNA using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

BRCA2 mutations in primary breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Mutation analysis in the BRCA2 gene in primary breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Review: analogies between trophoblastic and malignant cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

The presence of a pseudogene may affect the use of HPRT as an endogenous mRNA control in RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Low incidence of BRCA2 mutations in breast carcinoma and other cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

BRCA1, BRCA2, and DNA damage response: collision or collusion?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202903

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202903

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498873%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 October 2019

0 references

1 reference